Form 4: CME Group Executive Suzanne Sprague Reports Stock Transactions
SEC Form 4 Filing
Suzanne Sprague, Sr MD Global Head of Clearing at CME Group, reports the acquisition and disposal of company stock.
Summary
- On September 15, 2024, Suzanne Sprague surrendered 755 shares of CME Group Class A common stock at a price of $216.99 to cover tax obligations related to vesting restricted stock.
- On September 16, 2024, Ms. Sprague acquired 3,088 shares of CME Group Class A common stock at a price of $218.53.
- Following these transactions, Ms. Sprague directly owns 9,536 shares of CME Group Class A common stock.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard SEC filing reporting stock transactions.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency into the trading activities of key personnel at CME Group.
Stakeholder Impact
- The transactions could have a minor impact on shareholders due to the change in ownership, but the amounts are unlikely to be material.
Key Dates
| Date | Description |
|---|---|
| 09/15/2024 | 755 shares of Common Stock Class A disposed of to fulfill tax withholding obligations at $216.99. |
| 09/16/2024 | 3,088 shares of Common Stock Class A acquired at $218.53. |
| 09/17/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.